Bio-Techne declares $0.08 quarterly dividend, payment tied to Merck deal
Bio-Techne declared a $0.08 per share quarterly dividend, payable November 23 only if the Merck deal has not closed by the November 13 record date.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Bio-Techne has declared a quarterly dividend of $0.08 per share for the quarter ended September 30, 2026. The payment is scheduled for November 23 for shareholders on record as of November 13, but only if the pending Merck transaction has not closed by that record date.
According to TradingView, which relayed the release distributed by PR Newswire, the announcement included no comparison with the prior period.
why it matters
This is a routine quarterly payout, but its eligibility hinges on the timing of the Merck transaction. For investors, the key date is November 13: if the deal closes by then, the dividend will not be paid. The amount is small and unlikely to move the broader market.
tags
instruments
sources
- Bio-Techne Corporation (TECH) Declares $0.08 Quarterly Dividend — TradingView, 4 November 2026 at 01:30 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗